Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
03/29/2023* -- Results Q4 2022 -- -- --
11/09/2022 -- Results Q3 2022 -- -- --
08/09/2022 -- Results Q2 2022 -- -- --
05/10/2022 -- Results Q1 2022 -- -- --
03/29/2022 -- Results Q4 2021 -- -- --
11/12/2021 -- Results Q3 2021 -- -- --
08/10/2021 -- Results Q2 2021 -- -- --
05/10/2021 -- Results Q1 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 03/29/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/09/2022
Beat/Miss Upgrade
Return Since -10.66%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
Psychemedics Corp is a US-based company that provides testing services for the detection of drugs of abuse through the analysis of hair samples. The core business of the company is performing drug testing and reporting the results. Its drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The company also provides testimony to support the results of the tests. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The company operates through a single segment being Drug testing services.
URL https://www.psychemedics.com
Investor Relations URL http://investors.psychemedics.com/CorporateProfile
HQ State/Province Massachusetts
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Value
Next Earnings Release Mar. 29, 2023 (est.)
Last Earnings Release Nov. 09, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Dec. 01, 2022

Dividends

Dividend Per Share (TTM) 0.19
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 2.819
Yield to Sector 2.685
Yield to Industry 11.29
Last Dividend Amt. 0.07
Dividend Frequency Quarterly
Last Ex-Dividend Date Dec. 01, 2022
Yield (TTM) 3.78%
Forward Yield 5.04%
Payout Ratio -52.85%
Cash Payout Ratio 31.65%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
152.7%
-14.10%
-20.06%
-38.18%
-43.26%
38.87%
-27.73%
13.16%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
6.11%
--
--
--
--
54.43%
18.78%
-38.13%
8.64%
-88.50%
-99.97%
-99.39%
-89.16%
-15.67%
-56.75%
-53.55%
4.17%
-2.15%
19.27%
24.31%
-52.35%
107.0%
-47.43%
-63.01%
52.90%
-10.12%
-45.41%
-76.01%
-54.39%
38.08%
-28.97%
-66.47%
6.07%
As of January 27, 2023.

Profile

Edit
Psychemedics Corp is a US-based company that provides testing services for the detection of drugs of abuse through the analysis of hair samples. The core business of the company is performing drug testing and reporting the results. Its drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The company also provides testimony to support the results of the tests. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The company operates through a single segment being Drug testing services.
URL https://www.psychemedics.com
Investor Relations URL http://investors.psychemedics.com/CorporateProfile
HQ State/Province Massachusetts
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Value
Next Earnings Release Mar. 29, 2023 (est.)
Last Earnings Release Nov. 09, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Dec. 01, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

No data available
Symbol Dollars Invested % Weight
     
     
     
     
     
     
     
     
     
     

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter PMD Tweets